The Staging Option and Drug Development

dc.contributor.author	Lewis, Neal
dc.contributor.author	Enke, David
dc.contributor.author	Spurlock, David
dc.date.accessioned	2014-11-12T20:29:12Z
dc.date.available	2014-11-12T20:29:12Z
dc.date.issued	2005-11
dc.identifier.citation	Neal Lewis, David Enke, David Spurlock, “The Staging Option and Drug Development” Pharmaceutical Engineering, Vol. 25 No. 6, Nov/Dec 2005	en_US
dc.identifier.uri	https://scholarworks.bridgeport.edu/xmlui/handle/123456789/1014
dc.description.abstract	This article investigates the staging option to analyze an existing case study that involves the potential licensing of a drug compound that is in development. It demonstrates how options analysis is a useful tool in adding insight to the decision making process when conventional valuation methods are not decisive.	en_US
dc.language.iso	en_US	en_US
dc.publisher	International Society for Pharmaceutical Engineering	en_US
dc.subject	Engineering	en_US
dc.subject	Pharmaceuticals	en_US
dc.subject	Drug development	en_US
dc.title	The Staging Option and Drug Development	en_US
dc.type	Article	en_US
dc.publication.issue	6	en_US
dc.publication.name	Pharmaceutical Engineering	en_US
dc.publication.volume	25	en_US